-

Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today that its Ivenix Infusion System has been successfully implemented at San Luis Valley Health in Colorado.

San Luis Valley Health has been providing high-quality health services for more than 90 years, offering advanced techniques and technology along with a focus on patient care.

An innovative infusion system and smart pump designed to transform infusion delivery, the Ivenix Infusion System directly addresses the need to improve the safety of infusion pumps by rethinking every aspect of medication delivery to improve outcomes and help prevent IV-related medication errors. From the clear and simple smartphone-like touchscreen to EMR integration to real-time dose guidance with an up-to-date drug library, the Ivenix Infusion System empowers clinicians with intuitive usability.

“We are excited by the high-tech nature of the product and the focus on quality, safety, and work efficiencies,” said Roberta Bean, MSN, RN, NEA-BC, chief nursing officer at San Luis Valley Health. “This infusion system helps to relieve the pressure hospitals are experiencing with nurse resources because it’s easier to use, simpler to learn, and has a lot of safety features to make sure our patients get the care they deserve.”

The Ivenix Infusion System from Fresenius Kabi includes a large-volume pump, a portfolio of administration sets, and a suite of infusion management tools that seamlessly work together to inform care, advance clinical efficiency, and reduce costs. It features an administration set designed to accurately control drip rate whether loaded in or used outside of the pump, an intuitive cellphone-like touchscreen interface, and software and hardware that provide the freedom to operate effectively in any care environment.

“Our goal is to transform the present state of infusion therapy by delivering our large-volume infusion pumps to more hospitals,” said Pete Allen, senior vice president, IV Therapy at Fresenius Kabi USA. “We’re so proud to be partnering with San Luis Valley Health to place this groundbreaking technology into the hands of nurses and the extended care team.”

San Luis Valley Health is a regional health provider serving San Luis Valley, Colorado and beyond. In addition to its state-of-the-art hospital located in Alamosa, it also operates five clinics throughout the Valley and another hospital in Conejos County. San Luis Valley Health’s fully accredited 49-bed hospital in Alamosa provides outstanding care for those in need of general Medical/Surgical, Intensive Care, and labor and delivery hospital services. Conejos County Hospital serves the emergency and medical needs of individuals in Conejos and Costilla County.

About Fresenius Kabi

Fresenius Kabi (www.fresenius-kabi.com/us) is a global healthcare company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn.

Contacts

Matt Kuhn (847) 220-3033
matt.kuhn@fresenius-kabi.com

Fresenius Kabi


Release Versions

Contacts

Matt Kuhn (847) 220-3033
matt.kuhn@fresenius-kabi.com

Social Media Profiles
More News From Fresenius Kabi

Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara®

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced a new presentation of Otulfi® (ustekinumab-aauz) in a 45 mg/0.5 mL single-dose vial for subcutaneous injection. Otulfi® is a prescription medicine and the brand name for Fresenius Kabi’s FDA-approved biosimilar of the reference product, Stelara® (ustekinumab). With this addition, Fresenius Kabi now offers...

Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has launched Rocuronium Bromide Injection Room Temperature Stable (RTS), the first formulation of Rocuronium Bromide Injection that does not require refrigeration. Rocuronium Bromide Injection RTS was formulated to be stored at room temperature, eliminating the need for refrigeration, which is expected to streamline log...

Fresenius Kabi Expands Operating Room Portfolio with New Simplist® Prefilled Syringes

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its Simplist® portfolio of ready-to-administer prefilled syringes: Simplist® Ephedrine Sulfate Injection, USP and Simplist® Succinylcholine Chloride Injection, USP. Both medications are used in anesthesia and critical care, and their introduction extends the Simplist line...
Back to Newsroom